{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T11:02:59Z","timestamp":1793876579839,"version":"4.7.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.autrev.2024.103516","type":"journal-article","created":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T22:02:35Z","timestamp":1706047355000},"page":"103516","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Reprint of \u201cResidual pain in rheumatoid arthritis: Is it a real problem?\u201d"],"prefix":"10.1016","volume":"23","author":[{"given":"Piercarlo","family":"Sarzi-Puttini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margherita","family":"Zen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Arru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Giorgi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernest A.","family":"Choy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.autrev.2024.103516_bb0005","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s40744-019-00168-5","article-title":"Patient perceptions of unmet medical need in rheumatoid arthritis: a cross-sectional survey in the USA","volume":"6","author":"Radawski","year":"2019","journal-title":"Rheumatol Ther"},{"issue":"4","key":"10.1016\/j.autrev.2024.103516_bb0010","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/art.10515","article-title":"Preferences for improved health examined in 1,024 patients with rheumatoid arthritis: pain has highest priority","volume":"47","author":"Heiberg","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2024.103516_bb0015","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-014-0470-8","article-title":"Nociceptive neurons detect cytokines in arthritis","author":"Schaible","year":"2014","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"10.1016\/j.autrev.2024.103516_bb0020","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.pain.2010.11.014","article-title":"TNF-alpha contributes to spinal cord synaptic plasticity and inflammatory pain: distinct role of TNF receptor subtypes 1 and 2","volume":"152","author":"Zhang","year":"2011","journal-title":"Pain."},{"issue":"11","key":"10.1016\/j.autrev.2024.103516_bb0025","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1093\/rheumatology\/kex391","article-title":"Neuroendocrine and neurophysiological effects of interleukin 6 in rheumatoid Arthriti","volume":"57","author":"Choy","year":"2018","journal-title":"Rheumatology."},{"issue":"7","key":"10.1016\/j.autrev.2024.103516_bb0030","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1093\/rheumatology\/keac659","article-title":"Disproportionate articular pain is a frequent phenomenon in rheumatoid arthritis and responds to treatment with sarilumab","volume":"62","author":"Choy","year":"2023","journal-title":"Rheumatology (Oxford)."},{"issue":"1","key":"10.1016\/j.autrev.2024.103516_bb0035","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.semarthrit.2020.10.008","article-title":"The Jak\/STAT pathway: a focus on pain in rheumatoid arthritis","volume":"51","author":"Simon","year":"2021","journal-title":"Semin Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.autrev.2024.103516_bb0040","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.3390\/jcm8091394","article-title":"Effect of Baricitinib and adalimumab in reducing pain and improving function in patients with rheumatoid arthritis in low disease activity: exploratory analyses from RA-BEAM","volume":"8","author":"Fautrel","year":"2019","journal-title":"J Clin Med"},{"issue":"4","key":"10.1016\/j.autrev.2024.103516_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2022.103031","article-title":"Methotrexate in early rheumatoid arthritis: is the anchor drug still holding?","volume":"21","author":"Giollo","year":"2022","journal-title":"Autoimmun Rev"},{"issue":"2","key":"10.1016\/j.autrev.2024.103516_bb0050","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/ar3306","article-title":"The role of the central nervous system in the generation and maintenance of chronic pain in rheumatoid arthritis, osteoarthritis and fibromyalgia","volume":"13","author":"Lee","year":"2011","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"10.1016\/j.autrev.2024.103516_bb0055","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1136\/annrheumdis-2012-201506","article-title":"Incidence and predictors of secondary fibromyalgia in an early arthritis cohort","volume":"72","author":"Lee","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.autrev.2024.103516_bb0060","first-page":"1453","article-title":"Concomitant fibromyalgia complicating chronic inflammatory arthritis: a systematic review and meta-analysis","volume":"57","author":"Duffield","year":"2018","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"10.1016\/j.autrev.2024.103516_bb0065","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.autrev.2018.12.009","article-title":"Systemic rheumatic diseases: from biological agents to small molecules","volume":"18","author":"Sarzi-Puttini","year":"2019","journal-title":"Autoimmun Rev"},{"issue":"2","key":"10.1016\/j.autrev.2024.103516_bb0070","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2022-002658","article-title":"Treat-to-target in rheumatoid arthritis: a real-world study of the application and impact of treat-to-target within the wider context of patient management, patient centricity and advanced therapy use in Europe","volume":"8","author":"Taylor","year":"2022","journal-title":"RMD Open"},{"issue":"6","key":"10.1016\/j.autrev.2024.103516_bb0075","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1007\/s40744-022-00490-5","article-title":"Remission or not remission, That\u2019s the question: shedding light on remission and the impact of objective and subjective measures reflecting disease activity in rheumatoid arthritis","volume":"9","author":"Brkic","year":"2022","journal-title":"Rheumatol Ther"},{"issue":"1","key":"10.1016\/j.autrev.2024.103516_bb0080","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2022-002898","article-title":"Points to consider for cost-effective use of biological and targeted synthetic DMARDs in inflammatory rheumatic diseases: results from an umbrella review and international Delphi study","volume":"9","author":"van der Togt","year":"2023","journal-title":"RMD Open"},{"issue":"4","key":"10.1016\/j.autrev.2024.103516_bb0085","article-title":"Rheumatoid arthritis disease activity assessment in routine care: performance of the most widely used composite disease activity indices and patient-reported outcome measures","volume":"92","author":"Salaffi","year":"2021","journal-title":"Acta Biomed"},{"issue":"1","key":"10.1016\/j.autrev.2024.103516_bb0090","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.berh.2015.04.023","article-title":"How to measure chronic pain: new concepts","volume":"29","author":"Salaffi","year":"2015","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2024.103516_bb0095","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1136\/annrheumdis-2020-217344","article-title":"EULAR definition of difficult-to-treat rheumatoid arthritis","volume":"80","author":"Nagy","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2024.103516_bb0100","doi-asserted-by":"crossref","first-page":"1049875","DOI":"10.3389\/fmed.2022.1049875","article-title":"Difficult-to-treat rheumatoid arthritis: current concept and unsolved problems","volume":"9","author":"Watanabe","year":"2022","journal-title":"Front Med (Lausanne)"},{"issue":"6","key":"10.1016\/j.autrev.2024.103516_bb0105","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1093\/rheumatology\/keac563","article-title":"Early characterization of difficult-to-treat rheumatoid arthritis by suboptimal initial management: a multicentre cohort study","volume":"62","author":"Giollo","year":"2023","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2024.103516_bb0110","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41584-020-00541-7","article-title":"Persistent inflammatory and non-inflammatory mechanisms in refractory rheumatoid arthritis","volume":"17","author":"Buch","year":"2021","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2024.103516_bb0115","doi-asserted-by":"crossref","first-page":"18","DOI":"10.4081\/reumatismo.2014.760","article-title":"Pain in rheumatoid arthritis: a critical review","volume":"66","author":"Sarzi-Puttini","year":"2014","journal-title":"Reumatismo."},{"issue":"50","key":"10.1016\/j.autrev.2024.103516_bb0120","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/rheumatology\/keq327","article-title":"Improvements in patient-reported outcomes, symptoms of depression and anxiety, and their association with clinical remission among patients with moderate-to-severe active early rheumatoid arthritis","volume":"2011","author":"Kekow","year":"2011","journal-title":"Rheumatology."},{"issue":"3","key":"10.1016\/j.autrev.2024.103516_bb0125","doi-asserted-by":"crossref","first-page":"R83","DOI":"10.1186\/ar3353","article-title":"Pain persists in DAS28 rheumatoid arthritis remission but not in ACR\/EULAR remission: a longitudinal observational study","volume":"13","author":"Lee","year":"2011","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"10.1016\/j.autrev.2024.103516_bb0130","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/art.42429","article-title":"The biology of pain: through the rheumatology Lens","volume":"75","author":"Sunzini","year":"2023","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2024.103516_bb0135","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2020-001326","article-title":"Part of pain labelled neuropathic in rheumatic disease might be rather nociplastic","volume":"6","author":"Bailly","year":"2020","journal-title":"RMD Open"},{"key":"10.1016\/j.autrev.2024.103516_bb0140","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12974-016-0556-0","article-title":"Neuron-immune mechanisms contribute to pain in early stages of arthritis","volume":"13","author":"Nieto","year":"2016","journal-title":"J Neuroinflammation"},{"issue":"3","key":"10.1016\/j.autrev.2024.103516_bb0145","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/BOR.0000000000000929","article-title":"Fibromyalgia and centralized pain in the rheumatoid arthritis patient","volume":"35","author":"Minhas","year":"2023","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2024.103516_bb0150","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1002\/acr2.11488","article-title":"The problem of pain in rheumatology: clinical profiles associated with concomitant diagnoses with chronic overlapping pain conditions","volume":"4","author":"Falasinnu","year":"2022","journal-title":"ACR Open Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2024.103516_bb0155","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2022-002478","article-title":"The effect of tofacitinib on residual pain in patients with rheumatoid arthritis and psoriatic arthritis","volume":"8","author":"Dougados","year":"2022","journal-title":"RMD Open"},{"key":"10.1016\/j.autrev.2024.103516_bb0160","volume":"6","author":"Fautrel","year":"2020","journal-title":"RMD Open"},{"issue":"1","key":"10.1016\/j.autrev.2024.103516_bb0165","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13075-018-1541-z","article-title":"Effect of filgotinib, a selective JAK 1 inhibitor, with and without methotrexate in patients with rheumatoid arthritis: patient-reported outcomes","volume":"20","author":"Genovese","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2024.103516_bb0170","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1471-4159.2008.05566.x","article-title":"JAK\/STAT3 pathway is activated in spinal cord microglia after peripheral nerve injury and contributes to neuropathic pain development in rat","volume":"107","author":"Dominguez","year":"2008","journal-title":"J Neurochem"},{"issue":"5","key":"10.1016\/j.autrev.2024.103516_bb0175","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1080\/14397595.2017.1416940","article-title":"Residual symptoms and disease burden among patients with rheumatoid arthritis in remission or low disease activity: a systematic literature review","volume":"28","author":"Ishida","year":"2018","journal-title":"Mod Rheumatol"},{"issue":"8","key":"10.1016\/j.autrev.2024.103516_bb0180","doi-asserted-by":"crossref","first-page":"3778","DOI":"10.1093\/rheumatology\/keaa860","article-title":"Difficult-to-treat rheumatoid arthritis: contributing factors and burden of disease","volume":"60","author":"Roodenrijs","year":"2021","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"10.1016\/j.autrev.2024.103516_bb0185","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1007\/s00296-017-3792-4","article-title":"The influence of fibromyalgia on achieving remission in patients with long-standing rheumatoid arthritis","volume":"37","author":"Salaffi","year":"2017","journal-title":"Rheumatol Int"},{"issue":"7","key":"10.1016\/j.autrev.2024.103516_bb0190","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1136\/annrheumdis-2017-212862","article-title":"Defining refractory rheumatoid arthritis","volume":"77","author":"Buch","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.autrev.2024.103516_bb0195","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1136\/annrheumdis-2021-220973","article-title":"EULAR points to consider for the management of difficult-to-treat rheumatoid arthritis","volume":"81","author":"Nagy","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2024.103516_bb0200","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1136\/annrheumdis-2016-209724","article-title":"EULAR revised recommendations for the management of fibromyalgia","volume":"76","author":"Macfarlane","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.autrev.2024.103516_bb0205","first-page":"1666","article-title":"Pain is real; fibromyalgia isn\u2019t","volume":"30","author":"Ehrlich","year":"2003","journal-title":"J Rheumatol"},{"issue":"8","key":"10.1016\/j.autrev.2024.103516_bb0210","first-page":"1668","article-title":"Fibromyalgia and the medicalization of misery","volume":"30","author":"Hadler","year":"2003","journal-title":"J Rheumatol"},{"issue":"5","key":"10.1016\/j.autrev.2024.103516_bb0215","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/art.10225","article-title":"Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia","volume":"46","author":"Gracely","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.autrev.2024.103516_bb0220","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/art.21545","article-title":"The impact of a diagnosis of fibromyalgia on health care resource use by primary care patients in the UK: an observational study based on clinical practice","volume":"54","author":"Hughes","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.autrev.2024.103516_bb0225","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.semarthrit.2016.08.012","article-title":"2016 revisions to the 2010\/2011 fibromyalgia diagnostic criteria","volume":"46","author":"Wolfe","year":"2016","journal-title":"Semin Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.autrev.2024.103516_bb0230","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1177\/0141076817702530","article-title":"Trends in the incidence of chronic fatigue syndrome and fibromyalgia in the UK, 2001-2013: a clinical practice research datalink study","volume":"110","author":"Collin","year":"2017","journal-title":"J R Soc Med"},{"issue":"1","key":"10.1016\/j.autrev.2024.103516_bb0235","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3899\/jrheum.110668","article-title":"Pain thresholds in rheumatoid arthritis: the effect of tender point counts and disease duration","volume":"39","author":"Pollard","year":"2012","journal-title":"J Rheumatol"},{"issue":"7","key":"10.1016\/j.autrev.2024.103516_bb0240","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1093\/rheumatology\/keac671","article-title":"Non-inflammatory pain in inflammatory arthritis","volume":"62","author":"Das","year":"2023","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"10.1016\/j.autrev.2024.103516_bb0245","doi-asserted-by":"crossref","first-page":"R160","DOI":"10.1186\/ar2842","article-title":"The relationship between disease activity, sleep, psychiatric distress and pain sensitivity in rheumatoid arthritis: a cross-sectional study","volume":"11","author":"Lee","year":"2009","journal-title":"Arthritis Res Ther"},{"issue":"9","key":"10.1016\/j.autrev.2024.103516_bb0250","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nrrheum.2015.56","article-title":"The role of sleep-in pain and fibromyalgia","volume":"11","author":"Choy","year":"2015","journal-title":"Nat Rev Rheumatol"},{"issue":"12","key":"10.1016\/j.autrev.2024.103516_bb0260","doi-asserted-by":"crossref","first-page":"4015","DOI":"10.1002\/art.23063","article-title":"Collagen-induced arthritis as a model of hyperalgesia: functional and cellular analysis of the analgesic actions of tumor necrosis factor blockade","volume":"56","author":"Inglis","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.autrev.2024.103516_bb0265","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1093\/rheumatology\/kep458","article-title":"Fibromyalgic rheumatoid arthritis and disease assessment","volume":"49","author":"Pollard","year":"2010","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"10.1016\/j.autrev.2024.103516_bb0275","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1586\/ern.09.34","article-title":"Pain catastrophizing: a critical review","volume":"9","author":"Quartana","year":"2009","journal-title":"Expert Rev Neurother"},{"issue":"2","key":"10.1016\/j.autrev.2024.103516_bb0285","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1053\/eujp.2001.0313","article-title":"Somatosensory perception and function of diffuse noxious inhibitory controls (DNIC) in patients suffering from rheumatoid arthritis","volume":"6","author":"Leffler","year":"2002","journal-title":"Eur J Pain"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156899722400003X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156899722400003X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,7]],"date-time":"2024-04-07T19:49:46Z","timestamp":1712519386000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156899722400003X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S156899722400003X"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2024.103516","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reprint of \u201cResidual pain in rheumatoid arthritis: Is it a real problem?\u201d","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2024.103516","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2023.103423","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103516"}}